TD Waterhouse Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
TD Waterhouse Canada's REGN Position: Q2 2026 in Review
TD Waterhouse Canada reduced its Regeneron Pharmaceuticals (REGN) stake by 99% in Q2 2026, selling an estimated $2.12M and leaving 19 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1785.
TD Waterhouse Canada first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.51M in Q3 2025. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- TD Waterhouse Canada held 19 shares of Regeneron Pharmaceuticals worth $11.9K as of Q2 2026.
- TD Waterhouse Canada sold 3,114 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.12M.
- Regeneron Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1785 holding.
- TD Waterhouse Canada first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's Regeneron Pharmaceuticals position peaked at $5.51M in Q3 2025.
- 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.